Reported 765,387 shares, down 430,853 (36.0%) from the prior quarter.
Reported value -7.3%; share count -36.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 160745000 |
| 2022-03-31 | 96522000 |
| 2022-06-30 | 75634000 |
| 2022-09-30 | 92846000 |
| 2022-12-31 | 67298951 |
| 2023-03-31 | 78363762 |
| 2023-06-30 | 101826639 |
| 2023-09-30 | 75192096 |
| 2023-12-31 | 125260352 |
| 2024-03-31 | 114172737 |
| 2024-06-30 | 122761636 |
| 2024-09-30 | 112637713 |
| 2024-12-31 | 99258279 |
| 2025-03-31 | 105879202 |
| 2025-06-30 | 98107306 |
| 2025-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2025 | Reduced | 0 | -765,387 (-100.0%) | 0 | $0 | 2025-11-14 | |
| Q2 2025 | Reduced | 765,387 | -430,853 (-36.0%) | 0.03% | $98,107,306 | 2025-08-14 | |
| Q1 2025 | Added | 1,196,240 | +58,218 (5.1%) | 0.04% | $105,879,202 | 2025-05-15 | |
| Q4 2024 | Reduced | 1,138,022 | -79,683 (-6.5%) | 0.03% | $99,258,279 | 2025-02-12 | |
| Q3 2024 | Added | 1,217,705 | +78,703 (6.9%) | 0.04% | $112,637,713 | 2024-11-14 | |
| Q2 2024 | Reduced | 1,139,002 | -64,590 (-5.4%) | 0.04% | $122,761,636 | 2024-08-14 | |
| Q1 2024 | Reduced | 1,203,592 | -154,391 (-11.4%) | 0.04% | $114,172,737 | 2024-05-14 | |
| Q4 2023 | Reduced | 1,357,983 | -139,271 (-9.3%) | 0.05% | $125,260,352 | 2024-02-14 | |
| Q3 2023 | Reduced | 1,497,254 | -113,927 (-7.1%) | 0.03% | $75,192,096 | 2023-11-14 | |
| Q2 2023 | Reduced | 1,611,181 | -130,623 (-7.5%) | 0.04% | $101,826,639 | 2023-08-15 | |
| Q1 2023 | Added | 1,741,804 | +205,649 (13.4%) | 0.03% | $78,363,762 | 2023-05-15 | |
| Q4 2022 | Added | 1,536,155 | +127,048 (9.0%) | 0.03% | $67,298,951 | 2023-02-15 | |
| Q3 2022 | Reduced | 1,409,107 | -88,298 (-5.9%) | 0.04% | $92,846,000 | 2022-11-15 | |
| Q2 2022 | Reduced | 1,497,405 | -13,586 (-0.9%) | 0.03% | $75,634,000 | 2022-08-15 | |
| Q1 2022 | Added | 1,510,991 | +10,246 (0.7%) | 0.04% | $96,522,000 | 2022-05-13 | |
| Q4 2021 | Added | 1,500,745 | +106,541 (7.6%) | 0.06% | $160,745,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
465 managers reported BLUEPRINT MEDICINES CORP for Q2 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Reduced | 6,416,603 | -223,920 | 0.01% | $822,480,172 | 41 qtrs |
| BlackRock Inc | Reduced | 6,118,428 | -592,280 | 0.01% | $784,260,102 | 4 qtrs |
| Pentwater Capital Management LP | New | 3,900,000 | +3,900,000 | 3.24% | $499,902,000 | 1 qtr |
| HBK INVESTMENTS L P | New | 3,200,924 | +3,200,924 | 5.35% | $410,294,438 | 1 qtr |
| STATE STREET CORPORATION | Reduced | 2,230,980 | -453,137 | 0.01% | $285,967,016 | 41 qtrs |
| UBS Group AG | Added | 2,167,028 | +1,953,223 | 0.05% | $277,769,649 | 41 qtrs |
| FIL Ltd | New | 1,759,500 | +1,759,500 | 0.19% | $225,532,710 | 1 qtr |
| UBS OCONNOR LLC | Added | 1,713,587 | +1,698,722 | 5.96% | $219,647,582 | 14 qtrs |
| Barclays PLC | Added | 1,556,918 | +1,427,323 | 0.05% | $199,565,749 | 41 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 1,541,013 | +18,366 | 0.01% | $197,551,465 | 40 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2025
- Filed
- August 14, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 680,484
- Shared
- 0
- None
- 84,903
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.